- Home
- KOD vs NXDT Comparison
KOD vs NXDT Comparison
Compare KOD & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- NXDT
- Stock Information
- Founded
- KOD 2009
- NXDT 2012
- Country
- KOD United States
- NXDT United States
- Employees
- KOD N/A
- NXDT N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- NXDT Investment Managers
- Sector
- KOD Health Care
- NXDT Finance
- Exchange
- KOD Nasdaq
- NXDT Nasdaq
- Market Cap
- KOD 198.4M
- NXDT 223.1M
- IPO Year
- KOD 2018
- NXDT N/A
- Fundamental
- Price
- KOD $10.57
- NXDT $4.00
- Analyst Decision
- KOD Hold
- NXDT
- Analyst Count
- KOD 4
- NXDT 0
- Target Price
- KOD $11.25
- NXDT N/A
- AVG Volume (30 Days)
- KOD 681.7K
- NXDT 133.6K
- Earning Date
- KOD 08-13-2025
- NXDT 01-01-0001
- Dividend Yield
- KOD N/A
- NXDT 9.66%
- EPS Growth
- KOD N/A
- NXDT N/A
- EPS
- KOD N/A
- NXDT 0.99
- Revenue
- KOD N/A
- NXDT N/A
- Revenue This Year
- KOD N/A
- NXDT N/A
- Revenue Next Year
- KOD N/A
- NXDT N/A
- P/E Ratio
- KOD N/A
- NXDT $6.41
- Revenue Growth
- KOD N/A
- NXDT N/A
- 52 Week Low
- KOD $1.92
- NXDT $5.89
- 52 Week High
- KOD $11.60
- NXDT $13.07
- Technical
- Relative Strength Index (RSI)
- KOD 77.63
- NXDT 37.09
- Support Level
- KOD $7.69
- NXDT $3.86
- Resistance Level
- KOD $8.45
- NXDT $4.69
- Average True Range (ATR)
- KOD 0.83
- NXDT 0.32
- MACD
- KOD 0.17
- NXDT -0.08
- Stochastic Oscillator
- KOD 85.66
- NXDT 38.71
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.